InvestorsHub Logo
Followers 2
Posts 384
Boards Moderated 0
Alias Born 02/13/2017

Re: None

Thursday, 08/17/2017 11:37:59 AM

Thursday, August 17, 2017 11:37:59 AM

Post# of 34575
TapImmune has broken down and will continue to trend significantly lower. With extensions and amendments to recent trials, Team Wilson will continue to burn through cash again until new financing is required. The upcoming announcements concerning MAYO Paper and collaboration with AZN will only slow the slide in share value. TPIV not developing PolyStart at present pushing it forward several years. The is no earnings potential here for years and no acquisition potential unless the stock price is much lower. Wilson did it again, making commitments and not executing to schedule, spending all the cash and staying employed in FL, not bad for a retirement gig. In summary no revenue here for years and do not invest hoping for a buy-out it never works!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News